# DNA Methylation Biomarkers for Cervical Cancer Screening

> **NCT02605941** · — · UNKNOWN · sponsor: **iStat Biomedical CO., Ltd.** · enrollment: 5000 (estimated)

## Conditions studied

- Cervical Intraepithelial Neoplasia
- Cervical Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02605941
- **Lead sponsor:** iStat Biomedical CO., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2015-12
- **Final completion:** 2016-08
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2015-11-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02605941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02605941, "DNA Methylation Biomarkers for Cervical Cancer Screening". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02605941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*